WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4501 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 5661 Child (under 5 years) mortality rate: 682

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 6'131  5'933  5'741  5'558  5'382  3'939  3'273  2'415 
Births 230  226  222  217  212  159  143  112 
Surviving infants 220  216  211  206  201  149  129  98 
Pop. less than 5 years 1'034  1'008  985  960  938  671  605  449 
Pop. less than 15 years 2'642  2'554  2'470  2'393  2'322  1'852  1'523  1'117 
Female 15-49 years 1'501  1'456  1'412  1'368  1'324  897  763  563 

Number of reported case

(Click for retrospective incidence data for Eritrea)
Diphtheria
Japanese encephalitis
Measles 194  48  51  82  789 
Mumps 2'350  3'825  2'410  1'585  2'071  2'028 
Pertussis 208  91  11  30  152 
Polio*
Rubella 18  354  163  69  39 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 19  17  16  49  11 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Eritrea)
Vaccine year result method % card seen                                                
BCG          97  97  90  90  90  61 
DTP1          97  97  85  90  85  59 
DTP3          94  94  85  85  85  52 
HepB_BD         
HepB3          94  94  85  85  85 
Hib3          94  94  85  85  85 
JapEnc         
MCV          77  95  85  80  80  50 
MCV2         
PCV1         
PCV3         
Pol3          94  94  85  85  85  52 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  94  EPI   86.0  35  35  35  50  50  25 
PAB         
VAD1          95  95  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Eritrea)
BCG 99  99  99  99  99  89 
DTP1 99  99  99  99  99  88 
DTP3 99  99  99  99  99  81 
HepB3 99  99  99  99  99 
Hib3 99  99  99  99  99 
MCV 99  99  99  95  95  76 
PAB 94  93  93  86  86  80 
PCV3
Pol3 99  99  99  99  99  82 
Rota_last

Number of districts in the country 58  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 38
From 80 to 89% 10
From 50 to 79% 36
Less than 50% 16
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
HIB 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From July 2015
Rotavirus Yes From November 2013
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes 15-45 years
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2007-2011  2007-2011  2007-2011  2007-2011  2007-2011  2'006 
Nº of districts with microplans that include activities to raise immunization coverage number 58  58  58 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 58  58  58 
Nº districts with DTP3 coverage >=80% number 28  32 
% of districts with DTP3 coverage >=80% From 0 to 100% 48  55  12  17  17  17  17 
Nº districts with measles (MCV1) coverage >=95% number 17  12     
% of districts with MCV1 coverage >=95% From 0 to 100% 29  21     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No    No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 14        10 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.